Daiichi Sankyo, a global pharmaceutical company, is seeking opportunities to collaborate with institutes seeking protease inhibitors for disease treatment. Daiichi Sankyo has in‑house technology to make specific protease inhibitors and would ideally like to work with researchers who have identified proteases involved in mediating diseases, but who have not yet developed an inhibitor for the target protease.
Spinout Company
Research Project
Centre of Excellence
Academic Researcher
Spinout Company
Research Project
Centre of Excellence
Academic Researcher
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.